ET
Eliaz Therapeutics Inc.
SEC filingBiotechnology · Santa Rosa, CA
Amount raised$850Ksold at filing
Total offering$850K
Investors in the raise4count reported to the SEC
FiledOct 24, 2025first sale Mar 28, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Isaac EliazExecutive Officer, Director
Milton GossExecutive Officer
Executive officers, directors and promoters as listed on the Form D.